Silence Therapeutics (NASDAQ:SLN) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 4 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Silence Therapeutics, revealing an average target of $64.0, a high estimate of $75.00, and a low estimate of $49.00. The average price target has stayed the same, reflecting a consistent view from analysts.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Silence Therapeutics's perception among...
Login or create a forever free account to read this news
Sign up/Log in
